nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Local reaction—Fluorouracil—colon cancer	0.0199	0.0199	CcSEcCtD
Aztreonam—Serum creatinine increased—Irinotecan—colon cancer	0.0187	0.0187	CcSEcCtD
Aztreonam—Abdominal cramps—Vincristine—colon cancer	0.0175	0.0175	CcSEcCtD
Aztreonam—Abdominal cramps—Irinotecan—colon cancer	0.0171	0.0171	CcSEcCtD
Aztreonam—Joint swelling—Capecitabine—colon cancer	0.0157	0.0157	CcSEcCtD
Aztreonam—Sneezing—Capecitabine—colon cancer	0.0139	0.0139	CcSEcCtD
Aztreonam—Serum creatinine increased—Capecitabine—colon cancer	0.0125	0.0125	CcSEcCtD
Aztreonam—Leukocytosis—Fluorouracil—colon cancer	0.0117	0.0117	CcSEcCtD
Aztreonam—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.0114	0.0114	CcSEcCtD
Aztreonam—Laryngeal pain—Capecitabine—colon cancer	0.0113	0.0113	CcSEcCtD
Aztreonam—Mouth ulceration—Vincristine—colon cancer	0.0107	0.0107	CcSEcCtD
Aztreonam—Thrombophlebitis—Irinotecan—colon cancer	0.00966	0.00966	CcSEcCtD
Aztreonam—Petechiae—Capecitabine—colon cancer	0.00937	0.00937	CcSEcCtD
Aztreonam—Thrombophlebitis—Fluorouracil—colon cancer	0.00926	0.00926	CcSEcCtD
Aztreonam—Extrasystoles—Capecitabine—colon cancer	0.00917	0.00917	CcSEcCtD
Aztreonam—Swelling—Fluorouracil—colon cancer	0.00908	0.00908	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Irinotecan—colon cancer	0.00887	0.00887	CcSEcCtD
Aztreonam—Chest discomfort—Capecitabine—colon cancer	0.00872	0.00872	CcSEcCtD
Aztreonam—Ventricular extrasystoles—Capecitabine—colon cancer	0.00854	0.00854	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00837	0.00837	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00801	0.00801	CcSEcCtD
Aztreonam—Blood creatinine increased—Irinotecan—colon cancer	0.00784	0.00784	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00773	0.00773	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00753	0.00753	CcSEcCtD
Aztreonam—Candida infection—Capecitabine—colon cancer	0.00736	0.00736	CcSEcCtD
Aztreonam—Abdominal distension—Irinotecan—colon cancer	0.00728	0.00728	CcSEcCtD
Aztreonam—Pancytopenia—Vincristine—colon cancer	0.00705	0.00705	CcSEcCtD
Aztreonam—Sweating increased—Irinotecan—colon cancer	0.00704	0.00704	CcSEcCtD
Aztreonam—Petechiae—Methotrexate—colon cancer	0.00698	0.00698	CcSEcCtD
Aztreonam—Mouth ulceration—Capecitabine—colon cancer	0.00697	0.00697	CcSEcCtD
Aztreonam—Neutropenia—Vincristine—colon cancer	0.00694	0.00694	CcSEcCtD
Aztreonam—Eosinophilia—Fluorouracil—colon cancer	0.00686	0.00686	CcSEcCtD
Aztreonam—Neutropenia—Irinotecan—colon cancer	0.00676	0.00676	CcSEcCtD
Aztreonam—Pancytopenia—Fluorouracil—colon cancer	0.00658	0.00658	CcSEcCtD
Aztreonam—Phlebitis—Capecitabine—colon cancer	0.0065	0.0065	CcSEcCtD
Aztreonam—Thrombophlebitis—Capecitabine—colon cancer	0.00647	0.00647	CcSEcCtD
Aztreonam—Stomatitis—Vincristine—colon cancer	0.00645	0.00645	CcSEcCtD
Aztreonam—Swelling—Capecitabine—colon cancer	0.00635	0.00635	CcSEcCtD
Aztreonam—Jaundice—Irinotecan—colon cancer	0.00628	0.00628	CcSEcCtD
Aztreonam—Stomatitis—Irinotecan—colon cancer	0.00628	0.00628	CcSEcCtD
Aztreonam—Vascular purpura—Capecitabine—colon cancer	0.00626	0.00626	CcSEcCtD
Aztreonam—Stomatitis—Fluorouracil—colon cancer	0.00602	0.00602	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Capecitabine—colon cancer	0.00593	0.00593	CcSEcCtD
Aztreonam—Haemoglobin—Irinotecan—colon cancer	0.00582	0.00582	CcSEcCtD
Aztreonam—Purpura—Capecitabine—colon cancer	0.00581	0.00581	CcSEcCtD
Aztreonam—Haemorrhage—Irinotecan—colon cancer	0.00579	0.00579	CcSEcCtD
Aztreonam—Vaginal inflammation—Methotrexate—colon cancer	0.00574	0.00574	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.0056	0.0056	CcSEcCtD
Aztreonam—Diplopia—Capecitabine—colon cancer	0.0056	0.0056	CcSEcCtD
Aztreonam—Haemoglobin—Fluorouracil—colon cancer	0.00557	0.00557	CcSEcCtD
Aztreonam—Haemorrhage—Fluorouracil—colon cancer	0.00554	0.00554	CcSEcCtD
Aztreonam—Vaginal infection—Methotrexate—colon cancer	0.00542	0.00542	CcSEcCtD
Aztreonam—Flushing—Irinotecan—colon cancer	0.00537	0.00537	CcSEcCtD
Aztreonam—Blood creatinine increased—Capecitabine—colon cancer	0.00524	0.00524	CcSEcCtD
Aztreonam—Mouth ulceration—Methotrexate—colon cancer	0.00519	0.00519	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00504	0.00504	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00504	0.00504	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00494	0.00494	CcSEcCtD
Aztreonam—Abdominal distension—Capecitabine—colon cancer	0.00487	0.00487	CcSEcCtD
Aztreonam—Erythema—Fluorouracil—colon cancer	0.00482	0.00482	CcSEcCtD
Aztreonam—Thrombophlebitis—Methotrexate—colon cancer	0.00481	0.00481	CcSEcCtD
Aztreonam—Anaemia—Vincristine—colon cancer	0.00478	0.00478	CcSEcCtD
Aztreonam—Bronchospasm—Capecitabine—colon cancer	0.00476	0.00476	CcSEcCtD
Aztreonam—Sweating increased—Capecitabine—colon cancer	0.00471	0.00471	CcSEcCtD
Aztreonam—Ill-defined disorder—Irinotecan—colon cancer	0.00467	0.00467	CcSEcCtD
Aztreonam—Anaemia—Irinotecan—colon cancer	0.00466	0.00466	CcSEcCtD
Aztreonam—Vertigo—Vincristine—colon cancer	0.00465	0.00465	CcSEcCtD
Aztreonam—Pancytopenia—Capecitabine—colon cancer	0.0046	0.0046	CcSEcCtD
Aztreonam—Malaise—Irinotecan—colon cancer	0.00454	0.00454	CcSEcCtD
Aztreonam—Vertigo—Irinotecan—colon cancer	0.00453	0.00453	CcSEcCtD
Aztreonam—Neutropenia—Capecitabine—colon cancer	0.00452	0.00452	CcSEcCtD
Aztreonam—Convulsion—Vincristine—colon cancer	0.00448	0.00448	CcSEcCtD
Aztreonam—Anaemia—Fluorouracil—colon cancer	0.00446	0.00446	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Methotrexate—colon cancer	0.00442	0.00442	CcSEcCtD
Aztreonam—Myalgia—Vincristine—colon cancer	0.0044	0.0044	CcSEcCtD
Aztreonam—Cough—Irinotecan—colon cancer	0.0044	0.0044	CcSEcCtD
Aztreonam—Discomfort—Irinotecan—colon cancer	0.00424	0.00424	CcSEcCtD
Aztreonam—Anaphylactic shock—Vincristine—colon cancer	0.00422	0.00422	CcSEcCtD
Aztreonam—Jaundice—Capecitabine—colon cancer	0.00421	0.00421	CcSEcCtD
Aztreonam—Stomatitis—Capecitabine—colon cancer	0.00421	0.00421	CcSEcCtD
Aztreonam—Convulsion—Fluorouracil—colon cancer	0.00418	0.00418	CcSEcCtD
Aztreonam—Confusional state—Irinotecan—colon cancer	0.00415	0.00415	CcSEcCtD
Aztreonam—Thrombocytopenia—Vincristine—colon cancer	0.00413	0.00413	CcSEcCtD
Aztreonam—Anaphylactic shock—Irinotecan—colon cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Myalgia—Fluorouracil—colon cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Chest pain—Fluorouracil—colon cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Hyperhidrosis—Vincristine—colon cancer	0.00408	0.00408	CcSEcCtD
Aztreonam—Discomfort—Fluorouracil—colon cancer	0.00406	0.00406	CcSEcCtD
Aztreonam—Thrombocytopenia—Irinotecan—colon cancer	0.00403	0.00403	CcSEcCtD
Aztreonam—Hyperhidrosis—Irinotecan—colon cancer	0.00397	0.00397	CcSEcCtD
Aztreonam—Confusional state—Fluorouracil—colon cancer	0.00397	0.00397	CcSEcCtD
Aztreonam—Hypotension—Vincristine—colon cancer	0.00394	0.00394	CcSEcCtD
Aztreonam—Anaphylactic shock—Fluorouracil—colon cancer	0.00394	0.00394	CcSEcCtD
Aztreonam—Haemoglobin—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Aztreonam—Haemorrhage—Capecitabine—colon cancer	0.00387	0.00387	CcSEcCtD
Aztreonam—Hepatitis—Capecitabine—colon cancer	0.00387	0.00387	CcSEcCtD
Aztreonam—Thrombocytopenia—Fluorouracil—colon cancer	0.00386	0.00386	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Vincristine—colon cancer	0.00385	0.00385	CcSEcCtD
Aztreonam—Hypotension—Irinotecan—colon cancer	0.00384	0.00384	CcSEcCtD
Aztreonam—Insomnia—Vincristine—colon cancer	0.00382	0.00382	CcSEcCtD
Aztreonam—Paraesthesia—Vincristine—colon cancer	0.00379	0.00379	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00375	0.00375	CcSEcCtD
Aztreonam—Insomnia—Irinotecan—colon cancer	0.00372	0.00372	CcSEcCtD
Aztreonam—Paraesthesia—Irinotecan—colon cancer	0.00369	0.00369	CcSEcCtD
Aztreonam—Hypotension—Fluorouracil—colon cancer	0.00368	0.00368	CcSEcCtD
Aztreonam—Dyspnoea—Irinotecan—colon cancer	0.00367	0.00367	CcSEcCtD
Aztreonam—Erythema multiforme—Capecitabine—colon cancer	0.00366	0.00366	CcSEcCtD
Aztreonam—Tinnitus—Capecitabine—colon cancer	0.00361	0.00361	CcSEcCtD
Aztreonam—Pain—Vincristine—colon cancer	0.00361	0.00361	CcSEcCtD
Aztreonam—Flushing—Capecitabine—colon cancer	0.00359	0.00359	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00359	0.00359	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—colon cancer	0.00357	0.00357	CcSEcCtD
Aztreonam—Insomnia—Fluorouracil—colon cancer	0.00356	0.00356	CcSEcCtD
Aztreonam—Paraesthesia—Fluorouracil—colon cancer	0.00354	0.00354	CcSEcCtD
Aztreonam—Pain—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Aztreonam—Dyspnoea—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Aztreonam—Gastrointestinal pain—Vincristine—colon cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—colon cancer	0.00342	0.00342	CcSEcCtD
Aztreonam—Feeling abnormal—Irinotecan—colon cancer	0.00339	0.00339	CcSEcCtD
Aztreonam—Erythema—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—colon cancer	0.00337	0.00337	CcSEcCtD
Aztreonam—Pain—Fluorouracil—colon cancer	0.00337	0.00337	CcSEcCtD
Aztreonam—Gastrointestinal pain—Irinotecan—colon cancer	0.00336	0.00336	CcSEcCtD
Aztreonam—Abdominal pain—Vincristine—colon cancer	0.00334	0.00334	CcSEcCtD
Aztreonam—Body temperature increased—Vincristine—colon cancer	0.00334	0.00334	CcSEcCtD
Aztreonam—Dysgeusia—Capecitabine—colon cancer	0.0033	0.0033	CcSEcCtD
Aztreonam—Body temperature increased—Irinotecan—colon cancer	0.00325	0.00325	CcSEcCtD
Aztreonam—Abdominal pain—Irinotecan—colon cancer	0.00325	0.00325	CcSEcCtD
Aztreonam—Feeling abnormal—Fluorouracil—colon cancer	0.00324	0.00324	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—colon cancer	0.00313	0.00313	CcSEcCtD
Aztreonam—Ill-defined disorder—Capecitabine—colon cancer	0.00313	0.00313	CcSEcCtD
Aztreonam—Urticaria—Fluorouracil—colon cancer	0.00313	0.00313	CcSEcCtD
Aztreonam—Anaemia—Capecitabine—colon cancer	0.00312	0.00312	CcSEcCtD
Aztreonam—Body temperature increased—Fluorouracil—colon cancer	0.00311	0.00311	CcSEcCtD
Aztreonam—Hypersensitivity—Vincristine—colon cancer	0.00311	0.00311	CcSEcCtD
Aztreonam—Malaise—Capecitabine—colon cancer	0.00304	0.00304	CcSEcCtD
Aztreonam—Vertigo—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Aztreonam—Hypersensitivity—Irinotecan—colon cancer	0.00303	0.00303	CcSEcCtD
Aztreonam—Asthenia—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Aztreonam—Asthenia—Irinotecan—colon cancer	0.00295	0.00295	CcSEcCtD
Aztreonam—Cough—Capecitabine—colon cancer	0.00294	0.00294	CcSEcCtD
Aztreonam—Hypersensitivity—Fluorouracil—colon cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Diarrhoea—Vincristine—colon cancer	0.00289	0.00289	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—colon cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—colon cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Myalgia—Capecitabine—colon cancer	0.00287	0.00287	CcSEcCtD
Aztreonam—Chest pain—Capecitabine—colon cancer	0.00287	0.00287	CcSEcCtD
Aztreonam—Discomfort—Capecitabine—colon cancer	0.00284	0.00284	CcSEcCtD
Aztreonam—Diarrhoea—Irinotecan—colon cancer	0.00281	0.00281	CcSEcCtD
Aztreonam—Dizziness—Vincristine—colon cancer	0.00279	0.00279	CcSEcCtD
Aztreonam—Pruritus—Fluorouracil—colon cancer	0.00279	0.00279	CcSEcCtD
Aztreonam—Confusional state—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—colon cancer	0.00273	0.00273	CcSEcCtD
Aztreonam—Dizziness—Irinotecan—colon cancer	0.00272	0.00272	CcSEcCtD
Aztreonam—Diarrhoea—Fluorouracil—colon cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Thrombocytopenia—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—colon cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Vomiting—Vincristine—colon cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Rash—Vincristine—colon cancer	0.00266	0.00266	CcSEcCtD
Aztreonam—Hyperhidrosis—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Aztreonam—Dermatitis—Vincristine—colon cancer	0.00266	0.00266	CcSEcCtD
Aztreonam—Headache—Vincristine—colon cancer	0.00264	0.00264	CcSEcCtD
Aztreonam—Vomiting—Irinotecan—colon cancer	0.00261	0.00261	CcSEcCtD
Aztreonam—Dizziness—Fluorouracil—colon cancer	0.0026	0.0026	CcSEcCtD
Aztreonam—Rash—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Dermatitis—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Headache—Irinotecan—colon cancer	0.00258	0.00258	CcSEcCtD
Aztreonam—Hypotension—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Erythema—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Aztreonam—Nausea—Vincristine—colon cancer	0.00251	0.00251	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Aztreonam—Vomiting—Fluorouracil—colon cancer	0.0025	0.0025	CcSEcCtD
Aztreonam—Insomnia—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Aztreonam—Rash—Fluorouracil—colon cancer	0.00248	0.00248	CcSEcCtD
Aztreonam—Dermatitis—Fluorouracil—colon cancer	0.00248	0.00248	CcSEcCtD
Aztreonam—Paraesthesia—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Aztreonam—Headache—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—colon cancer	0.00246	0.00246	CcSEcCtD
Aztreonam—Dyspnoea—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Aztreonam—Nausea—Irinotecan—colon cancer	0.00244	0.00244	CcSEcCtD
Aztreonam—Pain—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Aztreonam—Nausea—Fluorouracil—colon cancer	0.00234	0.00234	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—colon cancer	0.00232	0.00232	CcSEcCtD
Aztreonam—Feeling abnormal—Capecitabine—colon cancer	0.00227	0.00227	CcSEcCtD
Aztreonam—Malaise—Methotrexate—colon cancer	0.00226	0.00226	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Aztreonam—Gastrointestinal pain—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Aztreonam—Cough—Methotrexate—colon cancer	0.00219	0.00219	CcSEcCtD
Aztreonam—Urticaria—Capecitabine—colon cancer	0.00219	0.00219	CcSEcCtD
Aztreonam—Abdominal pain—Capecitabine—colon cancer	0.00218	0.00218	CcSEcCtD
Aztreonam—Body temperature increased—Capecitabine—colon cancer	0.00218	0.00218	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—colon cancer	0.00217	0.00217	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Aztreonam—Hypersensitivity—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—colon cancer	0.00201	0.00201	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Aztreonam—Asthenia—Capecitabine—colon cancer	0.00197	0.00197	CcSEcCtD
Aztreonam—Pruritus—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Diarrhoea—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—colon cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Aztreonam—Dizziness—Capecitabine—colon cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Pain—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Vomiting—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Rash—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Dermatitis—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Headache—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—colon cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Nausea—Capecitabine—colon cancer	0.00163	0.00163	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—colon cancer	0.00163	0.00163	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Rash—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Headache—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Aztreonam—Nausea—Methotrexate—colon cancer	0.00122	0.00122	CcSEcCtD
